3D-QSAR Analysis on Pyrrolopyridine Analogs as Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2) Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 8, 2007-12 ,pp. : 557-561

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Activity Relationships of p38 Mitogen-Activated Protein Kinase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 9, 2005-01 ,pp. : 857-868

Bentham Science Publishers

Access to resources Recommend Favorite

Mitogen-activated protein kinase inhibitors suppress prostaglandin F 2 -induced myosin-light chain phosphorylation and contraction in iris sphincter smooth muscle

By Yousufzai S.Y.K.   Gao G.   Abdel-Latif A.A.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 17-26

Elsevier

Access to resources Recommend Favorite

Medium change amplifies mitogen-activated protein kinase-mediated prostaglandin E 2 synthesis in Swiss 3T3 fibroblasts

By Nakatani K.   Nakahata N.   Hamada Y.   Tsurufuji S.   Ohizumi Y.  

European Journal of Pharmacology, Vol. 356, Iss. 1, 1998-08 ,pp. : 91-100

Elsevier

Access to resources Recommend Favorite

p38α mitogen-activated protein kinase inhibitors, a patent review (2005 – 2011)

By Fischer Stefan   Koeberle Solveigh C   Laufer Stefan A  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 12, 2011-12 ,pp. : 1843-1866

Informa Healthcare

Access to resources Recommend Favorite